Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidylprolyl isomerase A pseudogene 11 (PPIAP11) is a human pseudogene that is homologous to the *peptidylprolyl isomerase A* (PPIA) gene, but sequence changes render it unable to encode a functional protein product. Like other pseudogenes, its primary biological activity is thought to occur at the RNA level, although there is no experimentally validated role for PPIAP11 specifically. Some pseudogenes in the PPIA family (not PPIAP11) have been implicated as regulatory long non-coding RNAs, but PPIAP11 has not been the focus of studies associating it with pathogenic or regulatory roles in disease. It is not considered a receptor, enzyme, transporter, or any conventional drug target class. If therapeutic or biological relevance is required for drug development or clinical application, another target must be selected.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 11 (PPIAP11).